Table 1 Baseline characteristics and procedural details at time of PFO-closure.
n = 124 | Amplatzer 52 | CardioSeal 3.3 | Helex 23 | PREMERE 16 | ||||
|---|---|---|---|---|---|---|---|---|
Demographic data | ||||||||
Age | 50.7 | ± 12.9 | 47.3 | ± 14.1 | 44.4 | ± 11.1 | 55.6 | ± 13.1 |
Male | 28 | 53.8% | 18 | 54.5% | 7 | 30.4% | 5 | 31.3% |
Female | 24 | 46.15% | 15 | 45.45% | 16 | 69.57% | 11 | 68.75% |
Follow-up [months] | 87.8 | ± 19.6 | 75.0 | ± 9.6 | 79.4 | ± 8.4 | 54.6 | ± 3.0 |
CAD | 13 | 25.0% | 5 | 15.2 | 3 | 13.0% | 7 | 43.8% |
Hyperlipidemia | 27 | 51.9% | 14 | 42.4% | 12 | 52.2% | 9 | 56.3% |
Hypertension | 26 | 50.0% | 10 | 30.3% | 8 | 34.8% | 6 | 37.5% |
Smoking | 15 | 28.8% | 8 | 24.2% | 2 | 8.7% | 2 | 12.5% |
Diabetes mellitus | 2 | 3.8% | 1 | 3.0% | 1 | 4.3% | 2 | 12.5% |
BMI (kg/m2) | 27.2 | ± 4.6 | 25.3 | ± 3.9 | 24.4 | ± 4.5 | 25.9 | ± 3.9 |
Peripheral embolism | 3 | 5.8% | 2 | 6.1% | 2 | 8.7% | 0 | 0.00% |
Central embolism | 4 | 7.7% | 3 | 9.1% | 2 | 8.7% | 1 | 6.3% |
TIA | 17 | 32.7% | 11 | 33.3% | 13 | 56.5% | 9 | 56.3% |
Stroke | 36 | 69.2% | 22 | 66.7% | 9 | 39.1% | 12 | 75.0% |
Medication | ||||||||
Aspirin | 24 | 46.2 | 14 | 42.4 | 10 | 43.5 | 11 | 68.8% |
VKA | 7 | 13.5 | 7 | 21.2 | 5 | 21.7 | 1 | 6.3% |
Clopidogrel | 1 | 1.9 | 2 | 6.1 | 1 | 4.3 | 4 | 25.0% |
ACEI | 8 | 15.4 | 5 | 15.2 | 1 | 2.0% | 2 | 12.5% |
Statins | 10 | 19.2 | 5 | 15.2 | 2 | 8.7 | 3 | 18.8% |
Diuretics | 1 | 1.9 | 0 | 0 | 0 | 0% | 1 | 6.3% |
CCB | 2 | 3.8 | 0 | 0 | 0 | 0% | 2 | 12.5% |
Echocardiographic data | ||||||||
Ejection fraction | 56.4 | ± 6.8 | 57.3 | ± 5.0 | 57.1 | ± 4.7 | 57.2 | ± 7.3 |
Left atrial diameter (mm) | 39.6 | ± 3.7 | 40.0 | ± 4.4 | 39.45 | ± 3.4 | 40.3 | ± 4.9 |
ASA | 27 | 51.9% | 17 | 51.2% | 10 | 43.5% | 14 | 85.7% |
Chiari network | 1 | 1.9% | 3 | 9.1% | 2 | 8.7% | 1 | 6.3% |
Eustachian valve | 14 | 26.9% | 3 | 9.1% | 3 | 13.0% | 4 | 25.0% |
Procedural data | ||||||||
Procedural success [%] | 100 | 100 | 100 | 100 | ||||
> 1 placement attempt | 6 | 11.5 | 2 | 6.1% | 3 | 13.0% | 0 | 0% |
Device size (mm) | 22-35 | 17-33 | 20-35 | 20-25 | ||||
Procedural complications | ||||||||
Device embolization | 1 | 1.9% | 0 | 0% | 0 | 0% | 0 | 0% |
Air embolization | 0 | 0% | 1 | 3.03% | 0 | 0% | 0 | 0% |
Pericardial effusion | 1 | 1.9% | 0 | 0% | 0 | 0% | 0 | 0% |
Paroxysmal atrial fibrillation | 1 | 1.9% | 1 | 3.03% | 0 | 0% | 0 | 0% |